Ophthalmology Tag

A French SME offers to biotech and pharma industries services or co-research based on analysis of microtubule cytoskeleton in the field of neurodegeneration   A French biotechnology start-up develops novel solutions to treat neurodegeneration, a process linked with microtubule disorders. It develops compounds to restore microtubule stability in glaucoma and thus secured assets and has become expert in microtubule analysis in various models and pathologies. Its expertise...

Read More

  A Spanish research centre, has jointly developed with a Israeli university, a family of compounds able to inhibit Semaphorin3A fostering nerve regeneration after injury. These compounds can be useful for treatment of ischemic events such as stroke, glaucoma and other optical nerve and retina insults. Biotech or pharmaceutical companies are sought for license agreement and/or research collaboration to perform preclinical assays.   After a neuronal damage is...

Read More